Entering text into the input field will update the search result below

Provectus To List On NYSE?

Jan. 20, 2014 4:20 PM ET6 Comments
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Value, Growth

Seeking Alpha Analyst Since 2010

I started investing while getting my Ph.D. at McGill University. My research was on behavioral correlates of neurological control of cardiovascular function. After 25 years as a Professor, I quit to do something more exciting and more difficult: live off of my investments. For quite some time, I specialized in Canadian Oil & Gas Trusts, other high income opportunities and special situations. In 2005, I founded the Trust Intelligence website to provide research and guidance to investors trying to wean them off of relying on sell-side analysts and to understand how to do due diligence from the point of view of an investor. My personal investment focus, and that on my website, is still on special situations and income investments in Canada and the USA. I am focused on looking at relative value and great managements with businesses that have the characteristics to give them superior potential. While I retain interesting in the petroleum & income sectors I not focus on a few biotech special situations because they can be transformative for people's health and their net worth.

In the company's latest Presentation


on page 29 at the bottom, they publicly mention listing on the NYSE for the first time. They have prepared to uplist to the NASDAQ for about a year, and even changed the Directors to comply with Regulations.

My view is that Provectus wants the widest audience for when it reports the contents of the FDA Minutes and other good news that's on its way, so their priority is speed.

I think that the Stock Exchange that offers the fastest listing, gets the business. For more details, you can check out the article here:


Disclosure: I am long PVCT, .

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.